News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,517 Results
Type
Article (42633)
Company Profile (294)
Press Release (668590)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (207528)
Career Advice (2252)
Deals (35868)
Drug Delivery (100)
Drug Development (82122)
Employer Resources (179)
FDA (16279)
Job Trends (15119)
News (350528)
Policy (33045)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (7)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2634)
Accelerated approval (5)
Adcomms (20)
Allergies (83)
Alliances (50503)
ALS (92)
Alzheimer's disease (1389)
Antibody-drug conjugate (ADC) (117)
Approvals (16274)
Artificial intelligence (250)
Autoimmune disease (20)
Automation (15)
Bankruptcy (365)
Best Places to Work (11759)
BIOSECURE Act (19)
Biosimilars (108)
Biotechnology (217)
Bladder cancer (61)
Brain cancer (27)
Breast cancer (264)
Cancer (2113)
Cardiovascular disease (174)
Career advice (1880)
Career pathing (30)
CAR-T (148)
Cell therapy (417)
Cervical cancer (19)
Clinical research (66618)
Collaboration (817)
Compensation (506)
Complete response letters (21)
COVID-19 (2640)
CRISPR (39)
C-suite (229)
Cystic fibrosis (100)
Data (2064)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (260)
Diagnostics (6437)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (119)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (92)
Earnings (86961)
Editorial (41)
Employer branding (21)
Employer resources (152)
Events (115021)
Executive appointments (706)
FDA (17471)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (733)
Gene editing (104)
Generative AI (21)
Gene therapy (298)
GLP-1 (719)
Government (4462)
Grass and pollen (4)
Guidances (51)
Healthcare (19031)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (115)
Indications (27)
Infectious disease (2783)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (93)
Interviews (376)
IPO (16648)
IRA (42)
Job creations (3783)
Job search strategy (1595)
Kidney cancer (10)
Labor market (36)
Layoffs (468)
Leadership (16)
Legal (8047)
Liver cancer (72)
Lung cancer (306)
Lymphoma (140)
Machine learning (5)
Management (59)
Manufacturing (293)
MASH (62)
Medical device (13407)
Medtech (13412)
Mergers & acquisitions (19733)
Metabolic disorders (672)
Multiple sclerosis (76)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (25)
Neuroscience (1911)
NextGen: Class of 2025 (6634)
Non-profit (4536)
Northern California (2561)
Now hiring (38)
Obesity (364)
Opinion (231)
Ovarian cancer (73)
Pain (82)
Pancreatic cancer (81)
Parkinson's disease (147)
Partnered (21)
Patents (226)
Patient recruitment (101)
Peanut (47)
People (58461)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20824)
Phase II (29370)
Phase III (21771)
Pipeline (1125)
Policy (131)
Postmarket research (2583)
Preclinical (8846)
Press Release (71)
Prostate cancer (99)
Psychedelics (31)
Radiopharmaceuticals (247)
Rare diseases (379)
Real estate (6110)
Recruiting (70)
Regulatory (22551)
Reports (46)
Research institute (2393)
Resumes & cover letters (374)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (68)
Series A (125)
Series B (85)
Service/supplier (11)
Sickle cell disease (54)
Southern California (2202)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3704)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (24)
The Weekly (30)
United States (22304)
Vaccines (679)
Venture capitalists (39)
Weight loss (241)
Women's health (34)
Worklife (15)
Date
Today (106)
Last 7 days (506)
Last 30 days (2537)
Last 365 days (33513)
2025 (9345)
2024 (35740)
2023 (40537)
2022 (51754)
2021 (56257)
2020 (54672)
2019 (47212)
2018 (35603)
2017 (32778)
2016 (32324)
2015 (38253)
2014 (32030)
2013 (27105)
2012 (29396)
2011 (30039)
2010 (28091)
Location
Africa (783)
Alabama (52)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (38963)
Australia (6527)
California (5850)
Canada (1941)
China (497)
Colorado (256)
Connecticut (267)
Delaware (136)
Europe (84487)
Florida (860)
Georgia (205)
Idaho (57)
Illinois (542)
India (25)
Indiana (300)
Iowa (9)
Japan (150)
Kansas (106)
Kentucky (24)
Louisiana (9)
Maine (62)
Maryland (864)
Massachusetts (4404)
Michigan (216)
Minnesota (379)
Mississippi (2)
Missouri (78)
Montana (30)
Nebraska (25)
Nevada (60)
New Hampshire (63)
New Jersey (1682)
New Mexico (30)
New York (1662)
North Carolina (963)
North Dakota (8)
Northern California (2561)
Ohio (197)
Oklahoma (14)
Oregon (33)
Pennsylvania (1317)
Puerto Rico (11)
Rhode Island (30)
South America (1170)
South Carolina (19)
South Dakota (1)
Southern California (2202)
Tennessee (100)
Texas (869)
Utah (174)
Virginia (139)
Washington D.C. (60)
Washington State (541)
West Virginia (3)
Wisconsin (52)
711,517 Results for "turn biotechnologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases
HanAll Biopharma Co., Ltd. has signed an exclusive licensing agreement with Turn Biotechnologies, Inc., a pre-clinical stage biopharmaceutical company focused on cellular repair through epigenetic reprogramming.
May 28, 2024
·
7 min read
Biotech Bay
Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies
Turn Biotechnologies announced an exclusive global licensing agreement with pharmaceutical manufacturer HanAll Biopharma to develop groundbreaking medicines for the treatment of age-related eye and ear conditions.
May 28, 2024
·
4 min read
Biotech Bay
Turn Biotechnologies Discussed Emerging Therapies at Aesthetic Plastic Surgery Society Meeting
Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, presented its breakthrough research and therapies to treat age-related diseases to members of the American Society for Aesthetic Plastic Surgery, known as The Aesthetic Society.
May 7, 2024
·
2 min read
Press Releases
Equipment Junction Turns Surplus Lab Gear into STEM Opportunities
April 1, 2025
·
1 min read
Job Trends
Difficult Market Turns More Biopharma Leaders to Fractional Roles, Say Experts
For reasons including downsizing, avoiding retirement and a tight labor market, senior-level biopharma professionals are increasingly turning to fractional roles, according to two recruitment experts.
August 28, 2024
·
4 min read
·
Angela Gabriel
Biotech Bay
Turn Biotechnologies’ Expands eTurna™ Delivery Platform to Solve Delivery and Targeting Issues that Challenge Industry
Turn Biotechnologies announced the expansion of its eTurna™ delivery platform that is expected to overcome the greatest challenge to breakthrough therapies: The safe and efficient targeting of specific organs and cells.
January 3, 2024
·
2 min read
Deals
Pharmas Turn to Licensing Deals as Risky Science Rises
Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the biotech ecosystem? Experts weigh in.
January 8, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Repair Biotechnologies and Genevant Sciences to Collaborate to Develop mRNA-LNP Therapy with First-in-Class Potential to Turn Back Atherosclerosis
September 27, 2024
·
2 min read
Biotech Bay
Turn Biotechnologies Co-Founder to Present at Prestigious ARDD Meeting in Copenhagen
Turn Biotechnologies co-founder Vittorio Sebastiano will share company data during a presentation on the potential of epigenetic reprogramming to increase human longevity during this week’s 10th Aging Research and Drug Discovery Meeting, the world’s largest longevity forum.
August 28, 2023
·
2 min read
Editorial
You Can’t Buy Us: Biotechs Turn to Courts to Fight Off Potential Buyers
Biogen’s effort to buy Sage against the board’s wishes and a long-time effort by investor Alcorn to scuttle Aurion’s IPO underscore the cutthroat nature of biopharma dealmaking.
January 31, 2025
·
3 min read
·
Annalee Armstrong
1 of 71,152
Next
